Abbott Laboratories 2009 SR
The report highlights Abbott's 2009 sustainability performance, focusing on four strategic priorities: innovating for the future, enhancing access, protecting patients, and safeguarding the environment. Key achievements include a 36 percent reduction in CO2 emissions since 2006 and a 580 million dollar investment in philanthropic grants and product donations. The company expanded its global presence with a new nutritional facility in Singapore and the acquisition of Solvay Pharmaceuticals. Abbott also maintained its inclusion in the Dow Jones Sustainability Index for the fifth consecutive year and was recognized as the most admired pharmaceutical company by Fortune.
Company: Abbott Laboratories
Sector: Industrials
Country: United States
Year: 2009
Type: SR
Pages: 44
Back to company
Abbott Laboratories
Global Citizenship Report
The report highlights Abbott's 2009 sustainability performance, focusing on four strategic priorities: innovating for the future, enhancing access, protecting patients, and safeguarding the environment. Key achievements include a 36 percent reduction in CO2 emissions since 2006 and a 580 million dollar investment in philanthropic grants and product donations. The company expanded its global presence with a new nutritional facility in Singapore and the acquisition of Solvay Pharmaceuticals. Abbott also maintained its inclusion in the Dow Jones Sustainability Index for the fifth consecutive year and was recognized as the most admired pharmaceutical company by Fortune.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2009
Reporting Period
Jan 1, 2009 - Dec 31, 2009
Fiscal Year
2009
Published
Apr 1, 2010
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women in Management
Employees